More News
18 March 2020
RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration16 March 2020
Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement15 March 2020
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline10 March 2020
Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline9 March 2020
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets2 March 2020
Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing2 March 2020
Gilead to Acquire Forty Seven for $4.9 Billion26 February 2020
Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease24 February 2020
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)20 February 2020
Tocagen and Forte Biosciences Announce MergerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports